LAMC2 acts as a novel therapeutic target of cetuximab in laryngeal cancer

In conclusion, LAMC2 may act as a novel anti-cancer target in LC.PMID:34533031 | DOI:10.4149/neo_2021_210421N549

Source: Neoplasma - September 17, 2021 Category: Cancer & Oncology Authors: Qin-Ying Wang Yong-Cai Liu Shui-Hong Zhou Hai-Hong Chen Source Type: research